Well-known for being the first physician-researcher in the United States to describe carmine allergy/anaphylaxis, Dr. James Baldwin — former training program director of the Allergy and Clinical Immunology Training Program — enjoys an international reputation for his research in this area. A member of the U-M faculty since 1994, he is an associate professor and division chief in the Division of Allergy and Clinical Immunology within the Department of Internal Medicine, and is board-certified in allergy and clinical immunology.
Dr. Baldwin has worked with the Food and Drug Administration to change labeling regulations, which now require carmine to be labeled by name on food labels (previously, it could be added to foods with nebulous descriptors such as “color added”). He has broad clinical interests, including allergic rhinitis, anaphylaxis, angioedema, asthma, drug allergies, urticaria, immune deficiencies and aspirin exacerbated respiratory disease.
A graduate of Connecticut College and the University of Connecticut School of Medicine, Dr. Baldwin in 1992 completed an internal medicine residency program at the University of Connecticut Affiliated Hospitals. In 1994, he completed fellowship training in allergy and clinical immunology at the Scripps Clinic and Research Foundation in La Jolla, California.